article thumbnail

STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements

STAT

Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. The oversight body noted the communications had not been subject to the regulatory approval process. A member of the U.K.

Vaccines 108
article thumbnail

The power of communication: engaging diverse groups in healthcare

pharmaphorum

Humans are diverse and communications to engage us need to be inclusive. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected. Today, people are culturally, socially, and demographically diverse.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is your digital communication strategy up to par?

pharmaphorum

Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges on communicating the advantages of your offerings to both prescribing providers and patients. This webinar will also explore: What’s next for digital healthcare communications. About the panel.

article thumbnail

Healthcare communication and how it’s changing

pharmaphorum

Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected by the changing world of digital communication. Fundamentally, the aims of healthcare communication haven’t changed, panellists said. And I think that’s changing a lot the way that we do communication.”.

article thumbnail

Does your copay program factor in differences across specialties? GoodRx analysis shows it should.

PharmaVoice

To address this gap, GoodRx is partnering with pharmaceutical companies to improve cost transparency and communication between patients and providers. New findings reveal an out-of-pocket cost gap between brand-name and generic prescriptions.

article thumbnail

Pharma needs to adapt its communications or be left behind

pharmaphorum

Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Healthcare companies that take this approach can improve their processes before commercialisation by breaking down internal silos.

article thumbnail

Responding to dynamic shifts in value communications

pharmaphorum

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies. The evolution of value in healthcare is a trend that has important implications for communications, particularly because ‘value’ is very much in the eye of the beholder.